News About: Goverment
Parliamentary government inspection opening on Oct. 11.
The parliamentary inspection of the government administration will open from Oct. 11 for 20 days until Oct. 30. The inspection to the health authorities was scheduled for the MOHW on Oct. 11, the KFDA on Oct. 12, the ...
Korea tightens rules on experimental cell therapy
The government is moving to make it more difficult to conduct clinical tests with stem cell therapy in emergency as problems arise from the fast-track processing of requests to conduct experimental cell therapy.
Th...
Clinicians get new protocol for anti-obesity drug
The Korea Food and Drug Administration (KFDA) unveiled a new set of protocols for anti-obesity drug based on some guidelines of the U.S. Food and Drug Administration and Europe's EMEA, which will be of much help to dr...
Drug industry putting off small packaged drug production.
The obligation of small packaged drug production seems not to be complied by the drug industry as originally scheduled to implement from Oct. 7.
The pharmaceutical industry raised its postponement claiming that the...
Prescriptions of potentially inappropriate medications for the elderly are soaring
Doctors are still prescribing potentially inappropriate medications for the elderly populations, according to a lawmaker.
Citing a report by the Health Insurance Review Agency, Rep. Ahn Myung-ok said elderly...
9 fold increase of obese patients for 5 years.
According to the NHIC report of "number of obese related disease patients and NHI payment" presented to Rep. Jang Bok-shim of Uri party during the National Assembly Health and Welfare Committee's meeting, number of ob...
KFDA approves Exelon for treatment of dementia associated With Parkinson's disease
Novartis Korea announced it has received from the Korea Food and Drug Administration an additional approval of Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's ...
KPMA agrees to supply drugs in 30-pill bottle
The Korea Pharmaceutical Manufacturer Association (KPMA), a local lobby group for drug makers, said on September 11 that it has reached an agreement with the Korea Pharmaceutical Association (KPA) over production of s...
National Reform Committee cool to agreement of smaller drug packs
The National Reform Committee (NRC) reacted coolly September 11 to the agreement of a controversial smaller packs issue between private organizations, the Korea Pharmaceutical Manufacturer Association and the Korea Ph...
Bio equivalency tests for 199 drugs to be reviewed.
The KFDA announced that about 130 drugs could be cancelled due to the bio equivalency test manipulation and other 199 drugs which were unable clearly to interpret the data (the items unable to recover its original dat...
